Ani Pharmaceuticals (ANIP) Net Income (2011 - 2026)
Ani Pharmaceuticals (ANIP) posted Net Income of $29.5 million for Q1 2026, up 7.15% sequentially from $27.5 million in Q4 2025, and up 88.0% YoY from $15.7 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Net Income (2011 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Net Income for 16 years, with the latest figure at $29.5 million in Q1 2026.
- Quarterly Net Income rose 88.0% year-over-year to $29.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92.2 million (up 537.39% YoY) and the FY2025 annual result came in at $78.3 million, up 522.94% from the prior year.
- Net Income climbed to $29.5 million in Q1 2026 per ANIP's latest filing, from $27.5 million in the prior quarter.
- Over five years, Net Income peaked at $29.5 million in Q1 2026 and troughed at -$24.2 million in Q3 2024.
- A 5-year average of $3.5 million and a median of $1.5 million in 2023 frame the typical range for Net Income.
- The sharpest annual moves came in 2022 and 2024: Net Income sank 23472.09% in 2022, then surged 1144.71% in 2024.
- Over 5 years, Net Income stood at -$4.3 million in 2022, then jumped by 126.96% to $1.2 million in 2023, then sank by 990.12% to -$10.3 million in 2024, then surged by 367.96% to $27.5 million in 2025, then climbed by 7.15% to $29.5 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered $29.5 million, $27.5 million, and $26.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -69.36 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 24.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.70 Mn |
| Mar 31, 2026 | 29.49 Mn |
| Dec 31, 2025 | 27.53 Mn |
| Sep 30, 2025 | 26.62 Mn |
| Jun 30, 2025 | 8.53 Mn |
| Mar 31, 2025 | 15.69 Mn |
| Dec 31, 2024 | -10.27 Mn |
| Sep 30, 2024 | -24.20 Mn |
| Jun 30, 2024 | -2.29 Mn |
| Mar 31, 2024 | 18.24 Mn |
| Dec 31, 2023 | 1.15 Mn |
| Sep 30, 2023 | 9.91 Mn |
| Jun 30, 2023 | 6.25 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | -4.28 Mn |
| Sep 30, 2022 | -8.60 Mn |
| Jun 30, 2022 | -14.92 Mn |
| Mar 31, 2022 | -20.10 Mn |
| Dec 31, 2021 | -24.14 Mn |
| Sep 30, 2021 | -4.42 Mn |